| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/25/2013 | US20130190334 N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS |
| 07/25/2013 | US20130190333 Pharmaceutical Combination |
| 07/25/2013 | US20130190332 Substituted Imidazo[1,2-a]pyrimidines and -pyridines |
| 07/25/2013 | US20130190330 Bisaryl-bonded aryltriazolones and use thereof |
| 07/25/2013 | US20130190326 Use of flibanserin for the treatment of post-menopausal sexual desire disorders |
| 07/25/2013 | US20130190320 Heterocyclic compounds and uses as anticancer agents |
| 07/25/2013 | US20130190317 Combination of compounds for treating or preventing skin diseases |
| 07/25/2013 | US20130190312 Modulators of hec1 activity and methods therefor |
| 07/25/2013 | US20130190306 Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp) |
| 07/25/2013 | US20130190301 Piroxicam for prophylactically and therapeutically treating herpes infections |
| 07/25/2013 | US20130190300 Compositions and methods for inhibiting the proliferation of cells |
| 07/25/2013 | US20130190299 Methods and compositions for treatment of multiple sclerosis |
| 07/25/2013 | US20130190296 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 07/25/2013 | US20130190294 Compounds and methods for treating diabetes |
| 07/25/2013 | US20130190290 Substituted phenylimidazopyrazoles and their use |
| 07/25/2013 | US20130190287 Therapeutically active compounds and their methods of use |
| 07/25/2013 | US20130190286 B-raf kinase inhibitors |
| 07/25/2013 | US20130190285 Method of treating pancreatic cancer |
| 07/25/2013 | US20130190283 Synthetic bile acid compositions and methods |
| 07/25/2013 | US20130190282 Formulations of deoxycholic acid and salts thereof |
| 07/25/2013 | US20130190281 Compositions Containing Satiogens and Methods of Use |
| 07/25/2013 | US20130190280 Anti-Diabetic Compounds |
| 07/25/2013 | US20130190279 Delayed-release glucocorticoid treatment of rheumatoid arthritis by improving signs and symptoms, showing major or complete clinical response and by preventing from joint damage |
| 07/25/2013 | US20130190278 Compounds for the Treatment/Prevention of Ocular Inflammatory Diseases |
| 07/25/2013 | US20130190276 Use of 5-h-dibenz/b,f/azepine-5-carboxamide derivatives in the treatment of neuropathic pain and neurological disorders |
| 07/25/2013 | US20130190275 Combined therapies of antipsychotic drugs and tetracyclines in the treatment of psychiatric disorders |
| 07/25/2013 | US20130190274 Topical drug delivery system with dual carriers |
| 07/25/2013 | US20130190270 Method for Improving Vein Performance in Bypass Surgery |
| 07/25/2013 | US20130190269 Polysaccharides compositions comprising fucans and galactans and their use to reduce extravasation and inflammation |
| 07/25/2013 | US20130190267 Polysaccharide-based polymer tissue adhesive for medical use |
| 07/25/2013 | US20130190265 Methods of Treating, Reducing the Incidence of, and/or Preventing Ischemic Events |
| 07/25/2013 | US20130190264 Trauma therapy |
| 07/25/2013 | US20130190263 Oral veterinarian composition for salmonids comprising 1-beta-d-ribofuranosyl-1h-1,2,4-triazole-3-carboxamide and use thereof in the treatment of infectious anemia in salmonids |
| 07/25/2013 | US20130190262 Compounds Useful for Inhibiting Chk1 |
| 07/25/2013 | US20130190261 Composition comprising xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof |
| 07/25/2013 | US20130190258 Compounds for inhibition of cancer cell proliferation |
| 07/25/2013 | US20130190251 Method for predicting the responsiveness to chemotherapy |
| 07/25/2013 | US20130190250 Polynucleotides Encoding Human Signal Peptide-Containing Proteins |
| 07/25/2013 | US20130190234 The use of alkylated semi-synthetic glycosaminoglycosan ethers for the treatment of dental disorders |
| 07/25/2013 | US20130190233 Peptides, derivatives and analogs thereof, and methods of using same |
| 07/25/2013 | US20130190229 Vitamin e formulations of sulfamide ns3 inhibitors |
| 07/25/2013 | US20130190227 Chitosan derivatives to treat animals or optimize animal health |
| 07/25/2013 | US20130189678 Macrophage migration inhibitory factor (mif) promoter polymorphism in inflammatory disease |
| 07/25/2013 | US20130189382 Use of fucoxanthin in the preparation of product for improving memory and having neuroprotective effect associated with neurodegenerative disorder |
| 07/25/2013 | US20130189380 Sphaeranthus indicus derived ingredients and their compositions for enhancing physical performance and energy levels |
| 07/25/2013 | US20130189376 Dialysis precursor composition |
| 07/25/2013 | US20130189374 Methods and compositions for enhancing iron absorption |
| 07/25/2013 | US20130189373 Method of Treating Cancer Using Combination of a Bifunctional Alkylating Agent and DNA Repair Inhibitors |
| 07/25/2013 | US20130189368 Nanoparticulate composition containing antibiotics for intramammary administration in animals |
| 07/25/2013 | US20130189361 Combination tablet with chewable outer layer |
| 07/25/2013 | US20130189359 Wet Granulation Using a Water Sequestering Agent |
| 07/25/2013 | US20130189358 Saxagliptin pharmaceutical formulations |
| 07/25/2013 | US20130189356 Pellet formulation for the treatment of the intestinal tract |
| 07/25/2013 | US20130189355 Compositions and methods for lowering levels of high-sensitivity (hs-crp) in a subject |
| 07/25/2013 | US20130189354 Novel Pharmaceutical Compositions for Treating Chronic Pain and Pain Associated with Neuropathy |
| 07/25/2013 | US20130189352 Liposome comprising combination of chloroquine and adriamycin and preparation method thereof |
| 07/25/2013 | US20130189350 Sustained release formulation of a non-steroidal anti-inflammatory drug |
| 07/25/2013 | US20130189349 Sustained-release liposomal anesthetic compositions |
| 07/25/2013 | US20130189348 Sustained release formulation of a non-steroidal anti-inflammatory drug |
| 07/25/2013 | US20130189343 Transmucosal administration system for a pharmaceutical drug |
| 07/25/2013 | US20130189342 Heterogeneous implantable devices for drug delivery |
| 07/25/2013 | US20130189318 Solid dispersions comprising tacrolimus |
| 07/25/2013 | US20130189317 Novel dosage and formulation |
| 07/25/2013 | US20130189316 Nanoemulsion composition containing vitamin k |
| 07/25/2013 | US20130189315 Therapeutic Polymeric Nanoparticles Comprising Vinca Alkaloids and Methods of Making and Using Same |
| 07/25/2013 | US20130189314 Enteric-coated ht-2157 compositions and methods of their use |
| 07/25/2013 | US20130189299 Composition for Lowering Blood Lipid and Elevating High-density Lipoprotein and Method for Manufacturing the Same |
| 07/25/2013 | US20130189276 Method inhibiting cell proliferation induced by alternatively spliced tissue factor |
| 07/25/2013 | US20130189275 Compositions and methods for inhibition of or treatment of dengue virus infection |
| 07/25/2013 | US20130189274 Phosphatidylinositol-3-kinase pathway biomarkers |
| 07/25/2013 | US20130189257 Use of pkc-iota inhibitors for the treatment of breast cancer |
| 07/25/2013 | US20130189248 Egfr inhibitor and antiviral agent for simultaneous, separate or sequential use in the treatment and/or prevention and/or palliation of cancer |
| 07/25/2013 | US20130189246 Treatment of ophthalmic conditions with fluorenone derivatives |
| 07/25/2013 | US20130189242 Hyaluronidase and Method of use Thereof |
| 07/25/2013 | US20130189240 Composition containing pias3 as an active ingredient for preventing or treating cancer or immune disease |
| 07/25/2013 | US20130189237 Co-enzyme q10 formulations and methods of use |
| 07/25/2013 | US20130189231 Composition for treatment of cartilage disease |
| 07/25/2013 | US20130189225 Methods of increasing efficiency of vector penetration of target tissue |
| 07/25/2013 | US20130189223 Methods and Compositions for Promoting Renal Repair and Regeneration |
| 07/25/2013 | US20130189221 Polysaccharide-based polymer tissue adhesive for medical use |
| 07/25/2013 | US20130189219 N-terminally chemically modified protein compositions and methods |
| 07/25/2013 | US20130189217 Methods of using ophthalmic compositions comprising povidone-iodine |
| 07/25/2013 | US20130189216 Linear polyol stabilized polyfluoroacrylate compositions |
| 07/25/2013 | US20130189215 Polyimidazoles for use as bile acid sequestrants |
| 07/25/2013 | US20130189194 Combinations of medicaments for the treatment of respiratory diseases |
| 07/25/2013 | US20130186829 Buffered compositions for dialysis |
| 07/25/2013 | US20130186801 Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| 07/25/2013 | DE102012001731A1 Systemische Darreichungsformen mit kontrollierter Freisetzung und verbesserter Stabilität Systemic dosage forms with controlled release and improved stability |
| 07/25/2013 | DE102012001146A1 Use of mannitol-/glucose mixture for producing drugs having diuretic effect during administration, preferably intravenous administration of iodinated X-ray contrast agent |
| 07/25/2013 | DE102012000976A1 Zusammensetzung für die topische Behandlung A composition for the topical treatment |
| 07/25/2013 | CA2863517A1 Substituted pyrimidine compounds and their use as syk inhibitors |
| 07/25/2013 | CA2863500A1 Eye drop composition |
| 07/25/2013 | CA2863343A1 Pyran-spirocyclic piperidine amides as modulators of ion channels |
| 07/25/2013 | CA2863228A1 Heterocyclic amide derivatives as p2x7 receptor antagonists |
| 07/25/2013 | CA2863158A1 Novel glycosyltransferase gene and use thereof |
| 07/25/2013 | CA2861442A1 Piperazinyl pyrimidine derivatives, preparation method and use thereof |
| 07/25/2013 | CA2861390A1 Tricyclic sulfonamide compounds and methods of making and using same |
| 07/25/2013 | CA2861381A1 Tricyclic sulfone compounds and methods of making and using same |
| 07/25/2013 | CA2861367A1 Chitosan-derived compositions |
| 07/25/2013 | CA2861350A1 Organic compounds |